MX9302324A - ENDOTHELINE II ANTAGONISTS. - Google Patents

ENDOTHELINE II ANTAGONISTS.

Info

Publication number
MX9302324A
MX9302324A MX9302324A MX9302324A MX9302324A MX 9302324 A MX9302324 A MX 9302324A MX 9302324 A MX9302324 A MX 9302324A MX 9302324 A MX9302324 A MX 9302324A MX 9302324 A MX9302324 A MX 9302324A
Authority
MX
Mexico
Prior art keywords
antagonists
endotheline
endoletine
levels
useful
Prior art date
Application number
MX9302324A
Other languages
Spanish (es)
Inventor
Wayne Livingston Cody
Annette Marian Doherty
John Gordon Topliss
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MX9302324A publication Critical patent/MX9302324A/en

Links

Landscapes

  • Removal Of Specific Substances (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen antagonistas novedosos de endotelina, así como métodos para la preparación y composiciones farmacéuticas de los mismos, que son útiles para tratar niveles elevados endoletina.Novel endothelin antagonists are described, as well as methods for the preparation and pharmaceutical compositions thereof, which are useful for treating elevated endoletine levels.

MX9302324A 1992-04-22 1993-04-21 ENDOTHELINE II ANTAGONISTS. MX9302324A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87222592A 1992-04-22 1992-04-22

Publications (1)

Publication Number Publication Date
MX9302324A true MX9302324A (en) 1993-10-01

Family

ID=25359100

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302324A MX9302324A (en) 1992-04-22 1993-04-21 ENDOTHELINE II ANTAGONISTS.

Country Status (2)

Country Link
CA (1) CA2094576A1 (en)
MX (1) MX9302324A (en)

Also Published As

Publication number Publication date
CA2094576A1 (en) 1993-10-23

Similar Documents

Publication Publication Date Title
DK0960107T3 (en) 6-Thiosubstituted paclitaxels
ES2096560T3 (en) COMPOSITIONS OF BENZOCICLOHEPTAPIRIDINA SUBSTITUTED WITH FLUORINE, COMPOSITIONS AND METHODS FOR USE AS ANTIHISTAMINIC COMPOUNDS.
AR010062A1 (en) NEW BENZAMIDALDEHYDE AND ITS USE
HN1996000017A (en) ISOTIAZOLONES
ES2058185T3 (en) DERIVATIVES OF CAMPTOTECINA AND PROCEDURE FOR ITS PREPARATION.
ES2151921T3 (en) DOLASTATINE ANALOG.
IT8821134A0 (en) PROCYANIDOL OLIGOMEROUS FRACTIONS, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
EA200100022A1 (en) COMPOSITIONS WITH CONTROLLED PAROXELETINE RELEASE
DE69905170T2 (en) THIAZOLOPYRIMIDINDERIVATE
MX9205678A (en) HETEROARILAMINES AS NEW INHIBITORS OF ACETYLCHOLINESTERASE.
AR008991A1 (en) DIMETHYL- (3-ARYL-BUT-3-ENYL) -AMINE COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND APPLICATION OF THEM
ES2164684T3 (en) USE OF TAQUIQUININE ANTAGONISTS IN THE EMESIS TREATMENT.
ES2167544T3 (en) BENZOTIAZINE DIOXIDS AS AN ENDOTHELINE ANTAGONISTS.
BR9909486A (en) Calcilic compounds
AR016981A2 (en) SYNTHETIC POLYPEPTIDES
SE9802937D0 (en) Novel compounds
ES2100689T3 (en) SYNERGIZING ASSOCIATION THAT HAS AN ANTAGONIST EFFECT ON NK1 AND NK2 RECEPTORS.
ES2095068T3 (en) POLYMERIC PEROXYCARBONATES AND PROCEDURE FOR PREPARING THEM.
ES2183923T3 (en) CHROMONE DERIVATIVES
EA199800753A1 (en) BENZOTIOPHENES, COMPOSITIONS THEIR CONTAINING AND METHODS USING THEM
ATE160573T1 (en) 1,3.5 (10) - ESTRATRIENIC DERIVATIVES WITH ORAL ACTION
MX9300406A (en) AZABICICLIC DERIVATIVES PROCEDURES FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN THEM.
EA200400670A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 3,4-PROPINOPPERHYDROPURINS AND THEIR APPLICATION FOR BLOCKING NEURAL TRANSMISSION
ES2171697T3 (en) ENDOTHELINE RECEIVER ANTAGONISTS.
DE69725459D1 (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINE AND 2-AMINOCYCLOHEPTA (B) BENZOFURANE